ADXS Advaxis Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: ADXS

Price (delayed)

$1.35

Market cap

$6.53M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$8.46

Enterprise value

-$18.66M

Advaxis, Inc. is a clinical-stage biotechnology company focused on the development and commercialization of proprietary Lm-based antigen delivery products. These immunotherapies are based on a platform technology that utilizes live ...

Highlights
The debt has dropped by 70% year-on-year and by 37% since the previous quarter
Advaxis's EPS has increased by 24% YoY and by 3.4% from the previous quarter
The quick ratio has soared by 107% YoY but it has contracted by 26% from the previous quarter
ADXS's revenue has plunged by 92% YoY
The gross profit has plunged by 92% YoY
Sector: Healthcare
Industry: Biotechnology
Website: http://www.advaxis.com
Peers: INO HSKA

Key stats

What are the main financial stats of ADXS
Market
Shares outstanding
4.84M
Market cap
$6.53M
Enterprise value
-$18.66M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
0.1
Price to sales (P/S)
9.82
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
-74.66
Earnings
Revenue
$250,000
EBIT
-$14.31M
EBITDA
-$14.23M
Free cash flow
-$15.25M
Per share
EPS
-$8.46
Free cash flow per share
-$8.38
Book value per share
$13.01
Revenue per share
$0.14
TBVPS
$14.2
Balance sheet
Total assets
$25.93M
Total liabilities
$2.3M
Debt
$12,000
Equity
$23.63M
Working capital
$23.46M
Liquidity
Debt to equity
0
Current ratio
11.18
Quick ratio
10.95
Net debt/EBITDA
1.77
Margins
EBITDA margin
-5,691.2%
Gross margin
100%
Net margin
-5,743.6%
Operating margin
-7,724%
Efficiency
Return on assets
-43.9%
Return on equity
-49%
Return on invested capital
N/A
Return on capital employed
-60.6%
Return on sales
-5,723.6%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ADXS stock price

How has the Advaxis stock price performed over time
Intraday
-10%
1 week
-12.9%
1 month
-10%
1 year
1,006.56%
YTD
12.5%
QTD
12.5%

Financial performance

How have Advaxis's revenue and profit performed over time
Revenue
$250,000
Gross profit
$250,000
Operating income
-$19.31M
Net income
-$14.36M
Gross margin
100%
Net margin
-5,743.6%
ADXS's revenue has plunged by 92% YoY
The gross profit has plunged by 92% YoY
The net income has grown by 20% year-on-year and by 6% since the previous quarter
The net margin has increased by 6% since the previous quarter

Growth

What is Advaxis's growth rate over time

Valuation

What is Advaxis stock price valuation
P/E
N/A
P/B
0.1
P/S
9.82
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
-74.66
Advaxis's EPS has increased by 24% YoY and by 3.4% from the previous quarter
The P/B is 90% below the 5-year quarterly average of 1.0 and 67% below the last 4 quarters average of 0.3
ADXS's equity is down by 39% YoY and by 16% QoQ
ADXS's revenue has plunged by 92% YoY
The P/S is 70% lower than the 5-year quarterly average of 32.2 and 49% lower than the last 4 quarters average of 19.2

Efficiency

How efficient is Advaxis business performance
ADXS's ROA is down by 23% YoY and by 9% from the previous quarter
The company's return on equity fell by 15% YoY and by 6% QoQ
Advaxis's ROS has increased by 6% from the previous quarter

Dividends

What is ADXS's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ADXS.

Financial health

How did Advaxis financials performed over time
The quick ratio has soared by 107% YoY but it has contracted by 26% from the previous quarter
The current ratio has surged by 104% year-on-year but it has declined by 29% since the previous quarter
The debt is 100% smaller than the equity
The debt has dropped by 70% year-on-year and by 37% since the previous quarter
ADXS's equity is down by 39% YoY and by 16% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.